https://www.webdisclosure.com/article/les-excellents-resultats-de-nemetschek-au-deuxieme-trimestre-incitent-a-recommander-lachat-K6ZSckpfxCa 2026-08-04T15:13:16.000Z WebDisclosure fr 2026-08-04T15:13:16.000Z Les excellents résultats de Nemetschek au deuxième trimestre incitent à recommander l'achat. Blog Nemetschek AG,DE0006452907,NEM,bourse,business,économie,finance,Marge D'EBITDA,Résultats Financiers Du Deuxième Trimestre,Quirin Privatbank,Nemetschek,Croissance Des Abonnements https://data.webdisclosure.com/images/JzWHaRA4yUT.jpg https://www.webdisclosure.com/article/nemetscheks-strong-q2-results-prompt-buy-recommendation-jatsOsHDLba 2026-08-04T15:13:16.000Z WebDisclosure en 2026-08-04T15:13:16.000Z Nemetschek's Strong Q2 Results Prompt Buy Recommendation Blog Nemetschek AG,DE0006452907,NEM,bourse,business,economy,finance,EBITDA Margin,Subscription Growth,Q2 Financial Results,Quirin Privatbank,Nemetschek https://data.webdisclosure.com/images/JzWHaRA4yUT.jpg https://www.webdisclosure.com/article/moderna-launches-clinical-trial-for-bundibugyos-ebolavirus-vaccine-JrGxPSL6TA3 2026-08-04T15:05:00.000Z WebDisclosure en 2026-08-04T15:05:00.000Z Moderna launches clinical trial for Bundibugyo's ebolavirus vaccine Blog Moderna, Inc.,US60770K1079,MRNA,bourse,business,economy,finance,Clinical Trial,Moderna,MRNA Vaccine,Phase 1,Ebolavirus Bundibugyo NASDAQ:MRNA https://data.webdisclosure.com/images/KVoVJ3M3bmK.jpg https://www.webdisclosure.com/article/moderna-lance-un-essai-clinique-pour-un-vaccin-contre-lebolavirus-de-bundibugyo-GnKBoWzNdco 2026-08-04T15:05:00.000Z WebDisclosure fr 2026-08-04T15:05:00.000Z Moderna lance un essai clinique pour un vaccin contre l'ébolavirus de Bundibugyo Blog Moderna, Inc.,US60770K1079,MRNA,bourse,business,économie,finance,Moderna,Essai Clinique,Phase 1,Vaccin ARNm,Ebolavirus Bundibugyo NASDAQ:MRNA https://data.webdisclosure.com/images/KVoVJ3M3bmK.jpg